![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Novartis |
---|---|
Information provided by: | Novartis |
ClinicalTrials.gov Identifier: | NCT00171522 |
To determine whether female patients have a preference for tegaserod of PEG 3350 relative to dosage form, convenience, ease of administration and taste
Condition | Intervention | Phase |
---|---|---|
Constipation |
Drug: Tegaserod and Polyethylene Glycol 3350 |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Crossover Assignment, Safety/Efficacy Study |
Official Title: | A Randomized, Open-Label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation |
Estimated Enrollment: | 52 |
Study Start Date: | May 2005 |
Study Completion Date: | September 2005 |
Ages Eligible for Study: | 18 Years to 64 Years |
Genders Eligible for Study: | Female |
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria may apply
United States, Arizona | |
Central Phoenix Medical Clinic, LLC | |
Phoenix, Arizona, United States, 85201 | |
Harmony Clinical Research | |
Oro Valley, Arizona, United States, 85739 | |
Adobe Gastroenterology, PC | |
Tucson, Arizona, United States, 85712 | |
United States, California | |
Associated Pharmaceutical Research Center, Inc | |
Buena Park, California, United States, 90620 | |
United States, Florida | |
Clinical Trial Management of Boca Raton, Inc. | |
Boca Raton, Florida, United States, 33486 | |
United States, Kansas | |
Health Science Center | |
Pratt, Kansas, United States, 67124 | |
United States, Massachusetts | |
Beth Israel Deacon Medical Center | |
Boston, Massachusetts, United States, 02215 | |
United States, Nebraska | |
Heartland Clinical Research, Inc | |
Omaha, Nebraska, United States, 68134 | |
United States, New Jersey | |
MBS Clinical Research, LLC | |
Margate, New Jersey, United States, 08402 | |
United States, Ohio | |
Midwest Clinical Research | |
Bellbrook, Ohio, United States, 45305 | |
United States, Tennessee | |
Associates in Gastroenterology | |
Hermitage, Tennessee, United States, 37076 | |
United States, Texas | |
R/D Clinical Research, Inc. | |
Lake Jackson, Texas, United States, 77566 | |
United States, Virginia | |
National Clinical Research, Inc | |
Richmond, Virginia, United States, 23294 | |
East Coast Clinical Research | |
Virginia Beach, Virginia, United States, 23454 |
Study ID Numbers: | CHTF919EUS49 |
Study First Received: | September 12, 2005 |
Last Updated: | January 31, 2008 |
ClinicalTrials.gov Identifier: | NCT00171522 |
Health Authority: | United States: Food and Drug Administration |
Constipation Tegaserod Polyethylene Glycol 3350 PEG |
Signs and Symptoms Signs and Symptoms, Digestive Constipation Serotonin Tegaserod |
Serotonin Agonists Neurotransmitter Agents Serotonin Agents |
Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Pharmacologic Actions |